市場調査レポート

Gタンパク質共役受容体 (GPCR) の世界市場 2014〜2022年 (cAMPアッセイ、カルシウム濃度検出アッセイ、GTPガンマS結合アッセイ、レポーター遺伝子アッセイ、受容体内在化アッセイ、cGMPアッセイ) - 業界分析、規模、シェア、成長、動向および予測

G-Protein Coupled Receptors (GPCRs) Market (Assay Type and Therapeutic Areas): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

発行 Transparency Market Research 商品コード 332665
出版日 ページ情報 英文 125 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
Gタンパク質共役受容体 (GPCR) の世界市場 2014〜2022年 (cAMPアッセイ、カルシウム濃度検出アッセイ、GTPガンマS結合アッセイ、レポーター遺伝子アッセイ、受容体内在化アッセイ、cGMPアッセイ) - 業界分析、規模、シェア、成長、動向および予測 G-Protein Coupled Receptors (GPCRs) Market (Assay Type and Therapeutic Areas): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022
出版日: 2015年05月29日 ページ情報: 英文 125 Pages
概要

当レポートは、世界のGタンパク質共役受容体 (GPCR) 市場について調査し、アッセイ別、治療分野別、地域別の動向、2012〜2022年の市場成長予測、および市場に参入する企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
  • 市場促進因子
    • 世界的に成長をつづける創薬およびADME毒性研究における最新/改良型GPCRアッセイ、アッセイシステム、プラットフォームの需要拡大
    • 循環器系、呼吸器系、生殖系疾患の罹患率および発症率の高さと世界的な癌と中枢神経疾患の発生率の常勝
    • 拡大する政府のイニシアティブ、提携/連携が技術的に進化したGPCRアッセイおよびアッセイシステムの需要を拡大
  • 市場阻害因子
    • 細胞株維持管理のコストの高さと高価な設備、装置がGPCRアッセイの需要を阻害
  • 市場の機会
    • 技術的に進化したGPCRアッセイ、アッセイシステム、プラットフォームの開発
  • ポーターズファイブフォース分析
  • バリューチェーン分析
  • 市場の魅力度分析
  • 競合環境

第4章 アッセイ別市場

  • イントロダクション
  • カルシウム濃度検出アッセイ
  • GTPガンマS結合アッセイ
  • cGMPアッセイ
  • レポーター遺伝子アッセイ
  • 受容体内在化アッセイ
  • cAMPアッセイ

第5章 治療分野別市場

  • イントロダクション
  • 循環器系
  • 中枢神経系
  • 呼吸器系
  • 免疫系
  • 生殖系
  • 腫瘍
  • その他の治療分野

第6章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の諸国

第7章 提言

第8章 企業プロファイル

  • Abcam plc
  • Becton, Dickinson and Company
  • Cisbio Bioassays
  • DiscoveRx Corporation
  • EMD Millipore Corporation
  • Enzo Life Sciences, Inc.
  • HD Biosciences Co. Ltd.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific, Inc.
目次

This report on G-protein coupled receptors (GPCRs) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of GPCR assays, cell lines, and consumables and entrants that are planning to invest in the GPCRs market. This report comprises an elaborate executive summary, which includes a market snapshot providing overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global GPCRs market with respect to the leading market segments based on types of products, applications and geographic regions.

The global GPCRs market has been segmented based on of assay type, therapeutic area, and geography. Based on assay type, the GPCRs market has been categorized into six major segments: cAMP assays, calcium level detection assays, GTPγS binding assays, reporter gene assays, receptor internalization assays, and cGMP assays. The market for these segments has been extensively analyzed based on of their effectiveness, usefulness, sales, and geographic presence. Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.

In terms of therapeutic areas, the market has been segmented into seven categories: cardiovascular system, central nervous system (CNS), respiratory system, immune system, reproductive system, oncology, and others (abdominal, urinary, orthopedics, etc.). Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.

The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that have strong impact on the GPCRs market currently and could influence the market in future as well. The market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. Porter's Five Forces analysis is also explained in this section to understand the GPCRs market considering different parameters that have an impact on the sustainability of the companies operating in the GPCRs market. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Geographically, the GPCRs market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Major geographic regions have been further divided into major national markets, viz. North America (the U.S. and Canada), Europe (Germany, the U.K., France, and Rest of Europe), and Asia Pacific (China, Japan, India, and Rest of Asia Pacific). Moreover, Rest of the World has been further subdivided into three regions: Latin America, the Middle East, and Africa. Market revenue in terms of USD million for the period between 2012 and 2022 along with the CAGR % from 2014 to 2022 are provided for all the regional and national markets considering 2013 as the base year.

The recommendations section included in the report would assist existing market players in expanding their market shares and new companies in establishing their presence in the global market. The report also profiles major players in the GPCRs market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Thermo Fisher Scientific, Inc., EMD (Merck) Millipore, Becton, Dickinson and Company, PerkinElmer, Inc., Cisbio Bioassays, Enzo Life Sciences, Inc., DiscoveRx Corporation, Sigma-Aldrich Corporation, QIAGEN N.V., Promega Corporation, Abcam plc, and HD Biosciences Co. Ltd.

The global GPCRs market is segmented as follows:

GPCRs Market, by Assay Type

  • Calcium Level Detection Assays
  • GTPγS Binding Assays
  • cGMP Assays
  • Reporter Gene Assays
  • Receptor Internalization Assay
  • cAMP Assays

GPCRs Market, by Therapeutic Area

  • Cardiovascular System
  • Central Nervous System
  • Respiratory System
  • Immune System
  • Reproductive System
  • Oncology
  • Others

GPCRs Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle East
    • Africa.

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
  • 1.4 Assumptions

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global G-Protein Coupled Receptors (GPCRs) Market
  • 2.2 Comparative Analysis: Global GPCRs Market Revenue, by Geography, 2013 & 2022 (Value %)

Chapter 3 Global G-Protein Coupled Receptors (GPCRs) Market Overview

  • 3.1 Introduction
  • 3.2 Market Drivers
    • 3.2.1 Rising Demand for Advanced/Improved GPCR Assays, Assay Systems and Platforms in Ever Growing Drug Discovery and ADME Toxicity Studies Worldwide
    • 3.2.2 High Prevalence and Incidence of Cardiovascular, Respiratory, and Reproductive Conditions along with Rising Occurrence of Cancers and Nervous System Disorders Globally
    • 3.2.3 Increased Government Initiatives and Partnerships/ Collaborations are Likely to Boost Demand for Technologically Advanced GPCR Assays and Assay Systems Worldwide
  • 3.3 Market Restraints
    • 3.3.1 High Cost Involved in the Maintenance of Cell Lines and Costly Equipment and Instruments could Restrain Demand for GPCR Assays
  • 3.4 Market Opportunities
    • 3.4.1 Development of Technologically Advanced GPCR Assays, Assay Systems and Assay Platforms
  • 3.5 Porter's Five Forces Analysis: Global GPCRs Market
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Threat of Substitutes
    • 3.5.4 Threat of New Entrants
    • 3.5.5 Competitive Rivalry
  • 3.6 Value Chain Analysis: GPCRs Market
  • 3.7 Market Attractiveness Analysis: Global GPCRs Market, by Geography
  • 3.8 Competitive Landscape
    • 3.8.1 Market Share Analysis, by Key Players: Global GPCRs Market, 2013 (Value %)

Chapter 4 Global G-Protein Coupled Receptors (GPCRs) Market, by Assay Type

  • 4.1 Introduction
    • 4.1.1 Global GPCRs Market Revenue, by Assay Type, 2012 - 2022 (USD Million)
    • 4.1.2 Comparative Analysis: Global GPCRs Market Revenue, by Assay Type, 2013 & 2022 (Value %)
  • 4.2 Calcium Level Detection Assays
    • 4.2.1 Global Calcium Level Detection Assays Market Revenue, 2012 - 2022 (USD Million)
  • 4.3 GTPγS Binding Assays
    • 4.3.1 Global GTPγS Binding Assays Market Revenue, 2012 - 2022 (USD Million)
  • 4.4 cGMP Assays
    • 4.4.1 Global cGMP Assays Market Revenue, 2012 - 2022 (USD Million)
  • 4.5 Reporter Gene Assays
    • 4.5.1 Global Reporter Gene Assays Market Revenue, 2012 - 2022 (USD Million)
  • 4.6 Receptor Internalization Assays
    • 4.6.1 Global Receptor Internalization Assays Market Revenue, 2012 - 2022 (USD Million)
  • 4.7 cAMP Assays
    • 4.7.1 Global cAMP Assays Market Revenue, 2012 - 2022 (USD Million)

Chapter 5 Global G-Protein Coupled Receptors (GPCRs) Market, by Therapeutic Areas

  • 5.1 Introduction
    • 5.1.1 Global GPCRs Market Revenue, by Therapeutic Areas, 2012 - 2022 (USD Million)
    • 5.1.2 Comparative Analysis: Global GPCRs Market Revenue, by Therapeutic Areas, 2013 & 2022 (Value %)
  • 5.2 Cardiovascular System
    • 5.2.1 Global GPCR Assays in Cardiovascular Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • 5.3 Central Nervous System (CNS)
    • 5.3.1 Global GPCR Assays in CNS Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • 5.4 Respiratory System
    • 5.4.1 Global GPCR Assays in Respiratory Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • 5.5 Immune System
    • 5.5.1 Global GPCR Assays in Immune System Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • 5.6 Reproductive System
    • 5.6.1 Global GPCR Assays in Reproductive System Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • 5.7 Oncology
    • 5.7.1 Global GPCR Assays in Oncology Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • 5.8 Other Therapeutic Areas
    • 5.8.1 Global GPCR Assays in Other Therapeutic Areas Market Revenue, 2012 - 2022 (USD Million)

Chapter 6 Global G-Protein Coupled Receptors (GPCRs) Market, by Geography

  • 6.1 Introduction
    • 6.1.1 Global GPCRs Market Revenue, by Geography, 2012 - 2022 (USD Million)
  • 6.2 North America
    • 6.2.1 North America GPCRs Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.2.2 United States
      • 6.2.2.1 United States GPCRs Market Revenue, 2012 - 2022 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe GPCRs Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.3.2 The United Kingdom
      • 6.3.2.1 United Kingdom GPCRs Market Revenue, 2012 - 2022 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany GPCRs Market Revenue, 2012 - 2022 (USD Million)
    • 6.3.4 France
      • 6.3.4.1 France GPCRs Market Revenue, 2012 - 2022 (USD Million)
    • 6.3.5 Rest of Europe
      • 6.3.5.1 Rest of Europe GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific GPCRs Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 China GPCRs Market Revenue, 2012 - 2022 (USD Million)
    • 6.4.3 Japan
      • 6.4.3.1 Japan GPCRs Market Revenue, 2012 - 2022 (USD Million)
    • 6.4.4 India
      • 6.4.4.1 India GPCRs Market Revenue, 2012 - 2022 (USD Million)
    • 6.4.5 Rest of Asia Pacific
      • 6.4.5.1 Rest of Asia Pacific GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • 6.5 Rest of the World (RoW)
    • 6.5.1 Rest of the World GPCRs Market Revenue, by Geography, 2012 - 2022 (USD Million)
    • 6.5.2 Latin America
      • 6.5.2.1 Latin America GPCRs Market Revenue, 2012 - 2022 (USD Million)
    • 6.5.3 Middle East
      • 6.5.3.1 Middle East GPCRs Market Revenue, 2012 - 2022 (USD Million)
    • 6.5.4 Africa
      • 6.5.4.1 Africa GPCRs Market Revenue, 2012 - 2022 (USD Million)

Chapter 7 Recommendations

  • 7.1 Develop Technologically Advanced GPCR Assays, Assay Systems and Platforms to Create Future Growth Opportunities
  • 7.2 Target Emerging Economies of the World for Higher Benefits
  • 7.3 Collaborate to Strengthen Market Presence

Chapter 8 Company Profiles

  • 8.1 Abcam plc
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Becton, Dickinson and Company
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent developments
  • 8.3 Cisbio Bioassays
    • 8.3.1 Company Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 DiscoveRx Corporation
    • 8.4.1 Company Overview
    • 8.4.2 Financial Overview
    • 8.4.3 Product Portfolio
    • 8.4.4 Business Strategies
    • 8.4.5 Recent Developments
  • 8.5 EMD Millipore Corporation
    • 8.5.1 Company Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Product Portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 Enzo Life Sciences, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product Portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent Developments
  • 8.7 HD Biosciences Co. Ltd.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Overview
    • 8.7.3 Product Portfolio
    • 8.7.4 Business Strategies
    • 8.7.5 Recent Developments
  • 8.8 PerkinElmer, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Overview
    • 8.8.3 Product Portfolio
    • 8.8.4 Business Strategies
    • 8.8.5 Recent Developments
  • 8.9 Promega Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Financial Overview
    • 8.9.3 Product Portfolio
    • 8.9.4 Business Strategies
    • 8.9.5 Recent Developments
  • 8.10 QIAGEN
    • 8.10.1 Company Overview
    • 8.10.2 Financial Overview
    • 8.10.3 Product portfolio
    • 8.10.4 Business Strategies
    • 8.10.5 Recent Developments
  • 8.11 Sigma-Aldrich Corporation
    • 8.11.1 Company Overview
    • 8.11.2 Financial Overview
    • 8.11.3 Product Portfolio
    • 8.11.4 Business Strategies
    • 8.11.5 Recent Developments
  • 8.12 Thermo Fisher Scientific, Inc.
    • 8.12.1 Company Overview
    • 8.12.2 Financial Overview
    • 8.12.3 Product portfolio
    • 8.12.4 Business Strategies
    • 8.12.5 Recent Developments

List of Figures

  • FIG. 1 G-Protein Coupled Receptors (GPCRs): Market Segmentation
  • FIG. 2 Global GPCRs Market Revenue, by Assay Type, 2013 (USD Million)
  • FIG. 3 Global GPCRs Market Revenue, by Therapeutic Areas, 2013 (USD Million)
  • FIG. 4 Comparative Analysis: Global GPCRs Market Revenue, by Geography, 2013 & 2022 (Value %)
  • FIG. 5 Porter's Five Forces Analysis: Global GPCRs Market
  • FIG. 6 Value Chain Analysis: Global GPCRs Market
  • FIG. 7 Market Attractiveness Analysis: Global GPCRs Market, by Geography, 2013
  • FIG. 8 Market Share Analysis, by Key Players: Global GPCRs Market, 2013 (Value %)
  • FIG. 9 Comparative Analysis: Global GPCRs Market Revenue, by Assay Type, 2013 & 2022 (Value %)
  • FIG. 10 Global Calcium Level Detection Assays Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 11 Global GTPγS Binding Assays Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 12 Global cGMP Assays Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 13 Global Reporter Gene Assays Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 14 Global Receptor Internalization Assays Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 15 Global cAMP Assays Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 16 Comparative Analysis: Global GPCRs Market Revenue, by Therapeutic Areas, 2013 & 2022 (Value %)
  • FIG. 17 Global GPCR Assays in Cardiovascular Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 18 Global GPCR Assays in CNS Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 19 Global GPCR Assays in Respiratory Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 20 Global GPCR Assays in Immune System Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 21 Global GPCR Assays in Reproductive System Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 22 Global GPCR Assays in Oncology Therapeutics Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 23 Global GPCR Assays in Other Therapeutic Areas Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 24 United States GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 25 Canada GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 26 United Kingdom GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 27 Germany GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 28 France GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 29 Rest of Europe GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 30 China GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 31 Japan GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 32 India GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 33 Rest of Asia Pacific GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 34 Latin America GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 35 Middle East GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 36 Africa GPCRs Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 37 Abcam plc: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 38 BD Biosciences: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 39 EMD Millipore Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 40 Enzo Life Sciences, Inc.: Annual Revenue, 2011 - 2013 (USD million)
  • FIG. 41 PerkinElmer, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 42 QIAGEN: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 43 Sigma-Aldrich Corporation: Annual Revenue, 2011 - 2013 (USD million)
  • FIG. 44 Thermo Fisher Scientific, Inc.: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global G-Protein Coupled Receptors (GPCRs) Market
  • TABLE 2 Global GPCRs Market Revenue, by Assay Type, 2012 - 2022 (USD Million)
  • TABLE 3 Global GPCRs Market Revenue, by Therapeutic Areas, 2012 - 2022 (USD Million)
  • TABLE 4 Global GPCRs Market Revenue, by Geography, 2012 - 2022 (USD Million)
  • TABLE 5 North America GPCRs Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 6 Europe GPCRs Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 7 Asia Pacific GPCRs Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 8 Rest of the World GPCRs Market Revenue, by Geography, 2012 - 2022 (USD Million)
Back to Top